Home » Topics » BioWorld Science

BioWorld Science
RSS

I-Mab Biopharma presents anti-CD73 antibodies for cancer

Sep. 4, 2018

TACI found to have prognostic value in heart failure

Sep. 4, 2018

MedImmune patents new fusion proteins for heart failure

Sep. 4, 2018

Kodiak completes enrollment in phase I study of KSI-301 in diabetic macular edema

Sep. 4, 2018

XPO5 gene polymorphism found to protect from coronary artery disease risk

Sep. 4, 2018

In rare encephalitis, neurons contribute to their own demise

Sep. 4, 2018

Dogs and Duchenne

Sep. 4, 2018

Filoviruses hide out in sperm production site

Sep. 4, 2018

AstraZeneca conducts first-in-human study of AZD-8154 in healthy subjects

Sep. 3, 2018

New phase II trial investigates MT-3724 with GEMOX in NHL

Sep. 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026